TransPerfect Life Sciences to Transform Clinical Development for Biocom Members
“TransPerfect was the clear choice for Biocom's VDR endorsement as the market leader in eTMF technology and translation services, combined with an aggressive and flexible VDR pricing structure, uninterrupted technical support, and industry-leading turnaround times.”
– Rick Fultz, Biocom
New York - TransPerfect, a leading provider of language services and e-clinical solutions to the life sciences industry, today announced a new partnership with Biocom. Through the multi-year agreement, Biocom members will receive discounted rates on TransPerfect’s full suite of services and technology solutions, including virtual data room (VDR) and electronic trial master file (eTMF) platform Trial Interactive.
Trial Interactive is a web-based, 21 CFR Part 11 compliant solution that eliminates the redundancies inherent in paper-based global clinical development and licensing of products. The platform will enable Biocom members to work more efficiently by allowing instant access to global documentation, providing a real-time metrics dashboard to enhance communications with licensing and alliance management partners.
“We are excited to introduce TransPerfect as our newest Platinum Supplier. They demonstrated the perfect mix of life science expertise, commitment to quality, unparalleled client service, global presence, and technological innovation throughout the vetting process. And most importantly, their leadership team was engaging and dedicated to making this program sustainable to all Biocom members, regardless of their size,” announced Biocom’s VP of Business Development, Rick Fultz. “TransPerfect was the clear choice for Biocom's VDR endorsement as the market leader in eTMF technology and translation services, combined with an aggressive and flexible VDR pricing structure, uninterrupted technical support, and industry-leading turnaround times.”
Michael Smyth, Life Sciences General Manager for TransPerfect, added, “We’re very proud that Biocom has chosen TransPerfect as a VDR, eTMF and translational services partner to streamline the global development and commercialization of products for the life sciences industry. Biocom’s global reach and commitment to influencing the life sciences industry plays a critical role in leveling the purchasing playing field. Biocom has a great team on a great mission, and we're excited to work alongside them and their member companies."
Biocom is a member driven organization providing unmatched opportunities and resources to help life science companies and their employees fulfill their business goals and improve life through advancements in health, energy and agriculture. Biocom offers member companies meaningful access to the influential drivers propelling the industry forward across all major life science sectors, including biotechnology, pharmaceutical, diagnostic, medical device, connected health, agriculture and biorenewable energy. As a company's most valuable and trusted partner, Biocom provides a tremendous range of initiatives and programs in public policy, capital development, group savings, professional network building and talent development. Biocom serves Southern California, a region offering the perfect climate for life science innovation because of its uniquely collaborative spirit, high concentration of world-class research institutions and its strong foundation for new company creation and development. For more information, visit www.biocom.org.
With annual revenues of over $400 million, TransPerfect is the world’s largest privately held provider of language services and technology solutions. From offices in 85 cities on five continents, TransPerfect offers a full range of services in 170+ languages to clients worldwide. With an unparalleled commitment to quality and client service, TransPerfect is fully ISO 9001 and EN 15038 certified. TransPerfect has global headquarters in New York, with regional headquarters in London and Hong Kong. For more information, please visit our website at www.transperfect.com.